The National Institute of Cancer (INC) is promoting the development of fundamental, clinical and policy research in the domain of oncology through its collaborations with various biomedical research and health care institutions in Luxembourg and abroad.

Cancer research in Luxembourg is conducted and/or supported by the following entities:

(listed by category and in alphabetical order)

Research institutions, infrastructures and platforms

• Agence eSanté
• Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC)
• Luxclin
• Luxembourg Institute of Health (LIH)
  • Department of Oncology
  • Department of Infection and Immunity
  • Department of Population Health
  • Integrated Biobank of Luxembourg (IBBL) – national infrastructure
• Registre National du Cancer (RNC)
• University of Luxembourg (UniLu)
  • Life Sciences Research Unit
  • LCSB Bioinformatics Core
  • Luxembourgish ELIXIR Node – European infrastructure

Funding

At the national level, public establishments conducting research in the domain of oncology are funded through various research grants, as well as through specialised infrastructure projects, as below:

• Luxembourg National Research Fund (FNR)

Further funding to cancer research is provided in the format of grants by some foundations fighting against cancer and by certain nonprofit projects:

• Action LIONS “Vaincre le Cancer”
• Fondation Cancer
• Fondatioun Kriibskrank Kanner
• Télévie

Ethics and data protection

Further information on certain aspects of research, such as ethics and data protection, may be found on the websites of the following organisations:

• National Research Ethics Committee (CNER)
• National Commission for Data Protection (CNPD)